Intravacc appoints Dr Jan Groen as CEO

Intravacc appoints Dr Jan Groen as CEO Bilthoven, The Netherlands – 07.00 CRT, April 3, 2020 – Intravacc, one of the leading translational research and development vaccine institutes with an extensive track record developing viral and bacterial vaccines from discovery to lead concept to clinical phase I/II, today announced the appointment of Dr. Jan Groen…